COLUMN GROUP III, LP → Tenaya Therapeutics, Inc. TNYA

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

5 13D/G filings on this issuer

4 other filings besides this one

Filer Track Record

3 filings by this filer

2 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 8.39

25,187,788 shares short · -0.3% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

1 holder · $27K

Point72 Asset Mgmt

Other 13D/G Filings on Tenaya Therapeutics, Inc.

Filed	Form	Filer	Stake	Shares
2025-05-14	SCHEDULE	COLUMN GROUP III, LP	30.30%	49,313,559	view →
2025-03-07	SCHEDULE	COLUMN GROUP III, LP	32.00%	49,313,559	view →
2025-03-07	SCHEDULE	Casdin Capital, LLC	4.30%	6,732,971	view →
2022-11-28	SC	Casdin Capital, LLC	—	—	view →

Other Filings by COLUMN GROUP III, LP

Filed	Form	Issuer	Stake	Shares
2025-05-14	SCHEDULE	Tenaya Therapeutics, Inc. TNYA	30.30%	49,313,559	view →
2025-03-07	SCHEDULE	Tenaya Therapeutics, Inc. TNYA	32.00%	49,313,559	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →